Purchasing agent of Iressa in India, Iressa in India, purchasing Iressa in India

() The efficacy of Indian Iressa in patients with locally advanced or metastatic non-small cell lung cancer who have previously received chemotherapy is based on the predetermined survival advantage of the Asian subgroup in a large-scale placebo-controlled clinical trial (note that the trial It has not been shown to improve disease-related symptoms and prolong survival in the overall population) and the survival data of uncontrolled clinical trials in China
/ ( () The results of two large randomized controlled clinical trials showed that gefitinib combined with Platinum chemotherapy regimens have not shown clinical benefit in the first-line treatment of locally advanced or metastatic disease, so such combination regimens are not recommended
/ ( ()
/ (